The growth of the UK’s ‘golden triangle’

By Ben Hargreaves contact

- Last updated on GMT

(Image: Getty/8213erika)
(Image: Getty/8213erika)

Related tags: United kingdom, London, Oxford, Cambridge, Biopharma hub

Research outlines the pace of growth in the UK’s biohub and how it will progress towards 2050.

The UK’s research centers have been at the heart of the global response to the COVID-19 pandemic, with the University of Oxford’s vaccine quickly adopted by AstraZeneca​, and Imperial College London’s effort not far behind in development​.

A recent report​ examines how the link between London, Oxford, and Cambridge – otherwise known as the ‘golden triangle’ – will spur further growth in the life sciences industry, and what needs to be done to support it.

Particularly, the report suggests that expansion of research space will be crucial to future expansion, as the cities lag behind other biopharma hubs, such as in the US.

Related news

Show more

Related product

The Reagents Behind Much of Molecular Biology

The Reagents Behind Much of Molecular Biology

Thermo Fisher Scientific | 25-Jul-2022 | Case Study

The ability to amplify, modify and fabricate DNA is fundamental to modern molecular biology. Why do so many researchers take their constituent parts for...

Related suppliers

Follow us

Products

View more

Webinars